Quick Take
Inari Medical (NARI) has filed to raise $110 million in an IPO of its common stock, per an amended registration statement.
The company sells medical devices to treat vein thrombosis and pulmonary embolism conditions.
NARI has produced enviable revenue growth and net profit results as it plans to use most of the IPO proceeds for additional R&D plans. The IPO appears reasonably valued so may be worth considering.
Company & Technology
Irvine, California-based Inari was founded to develop two catheter-based thrombectomy FDA-approved devices to treat patients with deep vein thrombosis